Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
Current Neuropharmacology
|
April 6, 2023
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis
Francesca De Vito, Sara Balletta, Silvia Caioli, et al.
Frontiers in Molecular Neuroscience
|
August 22, 2024
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis
Luana Gilio, Diego Fresegna, Mario Stampanoni Bassi, et al.
Frontiers in Immunology
|
June 24, 2024
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis
Krizia Sanna, Antonio Bruno, Sara Balletta, et al.
Neurobiology of Disease
|
July 14, 2022
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis
Luana Gilio, Diego Fresegna, Antonietta Gentile, et al.
Cells
|
February 10, 2021
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis
Georgia Mandolesi, Francesca Romana Rizzo, Sara Balletta, et al.
Neuropathology and Applied Neurobiology
|
September 7, 2021
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis
Francesca De Vito, Alessandra Musella, Diego Fresegna, et al.
Brain, Behavior, and Immunity
|
March 4, 2026
Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement
Alessandra Musella, Sara Balletta, Claudia Russo, et al.
Developmental Cell
|
December 5, 2018
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis
Juliane Becher, Luca Simula, Elisabetta Volpe, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
Current Neuropharmacology
|
April 6, 2023
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis
Francesca De Vito, Sara Balletta, Silvia Caioli, et al.
Frontiers in Molecular Neuroscience
|
August 22, 2024
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis
Luana Gilio, Diego Fresegna, Mario Stampanoni Bassi, et al.
Frontiers in Immunology
|
June 24, 2024
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis
Krizia Sanna, Antonio Bruno, Sara Balletta, et al.
Neurobiology of Disease
|
July 14, 2022
Preventive exercise attenuates IL-2-driven mood disorders in multiple sclerosis
Luana Gilio, Diego Fresegna, Antonietta Gentile, et al.
Cells
|
February 10, 2021
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis
Georgia Mandolesi, Francesca Romana Rizzo, Sara Balletta, et al.
Neuropathology and Applied Neurobiology
|
September 7, 2021
MiR-142-3p regulates synaptopathy-driven disease progression in multiple sclerosis
Francesca De Vito, Alessandra Musella, Diego Fresegna, et al.
Brain, Behavior, and Immunity
|
March 4, 2026
Physical exercise modulates T cell activity and mitigates synaptic dysfunction in multiple sclerosis through vagus nerve engagement
Alessandra Musella, Sara Balletta, Claudia Russo, et al.
Developmental Cell
|
December 5, 2018
AMBRA1 Controls Regulatory T-Cell Differentiation and Homeostasis Upstream of the FOXO3-FOXP3 Axis
Juliane Becher, Luca Simula, Elisabetta Volpe, et al.
Page
of 8